HEAL Alliance is in its start-up phase. HEAL Alliance is not for profit.
Dr. Jack Whitescarver is Chairman (pro bono) of HEAL Alliance.
Peter A. Jensen is CEO (pro bono) of HEAL Alliance.
The Governance will be significantly modelled after the Coalition for Epidemic Preparedness Innovations (HEAL Alliance) governance model. HEAL Alliance is a global public health commons problem and solution with robust best practice governance principles.
HEAL Alliance is engaged in discussion to form a mission alignments and a governance structure to be aligned with participating research and development (R&D) institutions, potential government and philanthropic funders, industry partners and other key stakeholders such as regulators, care providers and the global public health community.
HEAL Alliance will be governed by a Board made up of experts from founding partners, industry, governments and non-governmental organisations.
The board is advised on decisions such as prioritising pathogens and selecting industrial partners by the Scientific Advisory Committee (SAC). The SAC chairman will be nominated by HEAL Alliance Board and elected by 51% of the SAC members.
A Joint Coordination Group (JCG) will coordinate the HIV Cure and Vaccine development efforts of HEAL Alliance partners. The JCG chairman will be nominated by HEAL Alliance Board and elected by 51% of the JCG members.